Skip to main content

Table 1 Baseline characteristics of patients with retinal angiomatous proliferation

From: One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages

 

Group I

Group II

Group III

p value

Mean age (years)

64.75 ± 14.58

63.41 ± 11.04

72.18 ± 9.68

0.180

Number (Male/Female)

8 ( 4/4)

17 (7/10)

16 (5/11)

0.662

Mean BCVA (logMAR)

0.441 ± 0.24

0.602 ± 0.26

0.831 ± 0.56

0.105

Mean CMT (μm)

254.43 ± 57.29

289.78 ± 66.46

372.72 ± 127.14

0.040*

  1. BCVA, best-corrected visual acuity; CMT, central macular thickness
  2. *P < 0.05
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us